Transcendent Capital Group LLC Charles River Laboratories International, Inc. Transaction History
Transcendent Capital Group LLC
- $195 Billion
- Q3 2024
A detailed history of Transcendent Capital Group LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Transcendent Capital Group LLC holds 3 shares of CRL stock, worth $547. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3
Previous 3
-0.0%
Holding current value
$547
Previous $620,000
4.68%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
718Shares Held
51.8MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.11 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$928 Million0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$381 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$348 Million0.99% of portfolio
-
Allspring Global Investments Holdings, LLC1.76MShares$321 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.28B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...